French oncology group has scaled its US operations from 10-person startup to 600-employee operation using data analytics and patient engagement technology
SERVIER
French oncology group has scaled its US operations from 10-person startup to 600-employee operation using data analytics and patient engagement technology
Servier Pharmaceuticals has built its US operations around technology integration across drug discovery, patient services and commercial activities. The French pharmaceutical company, which opened its first laboratory in Orleans in 1954, entered the US market in 2018 with 10 employees in a Boston conference room.
Initially operating from a hotel before moving to a co-location working facility with 70 employees during the first year, the organisation quickly outgrew these initial premises. Servier now occupies two floors of its current building and employs more than 600 people across five marketed products: reflecting the company’ s oncology focus and systematic approach to technology deployment across its operations.
Servier addresses pharmaceutical industry development challenges through technology The pharmaceutical development process presents statistical challenges that technology helps address. Drug development operates as a numbers game with lengthy odds, where thousands of initial compounds fail to reach market approval.
80 December 2025